UCSB Arts & Lectures and the Cancer Foundation of Santa Barbara host the Nobel Prize–winning biochemist for a talk on CRISPR ...
Co-hosted by UC Santa Barbara Arts & Lectures and the Cancer Foundation of Santa Barbara, the talk will discuss CRISPR-Cas9 ...
Jennifer Doudna on the Brave New World Being Ushered In by Gene Editing The technology’s promise can sound like science fiction—it might help us adapt to a radically different climate ...
Jennifer Doudna on the Brave New World Being Ushered In by Gene Editing The technology’s promise can sound like science fiction—it might help us adapt to a radically different climate ...
The technology’s promise can sound like science fiction—it might help us adapt to a radically different climate, or grow organs for people in need—but experts are also concerned about its potential ...
Editas Medicine (EDIT – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Jack Allen ...
JonesTrading analyst Soumit Roy has assigned their bullish stance on EDIT stock, giving a Buy rating today. Soumit Roy’s rating is based ...
JonesTrading analyst Debanjana Chatterjee has assigned their bullish stance on NTLA stock, giving a Buy rating on October 16. Debanjana ...
BMO Capital analyst Kostas Biliouris maintained a Buy rating on Intellia Therapeutics (NTLA – Research Report) today and set a price ...
Plunkitt of Tammany Hall,” a collection of political sermons attributed to a crooked machine boss, is a handy reference for ...
Jennifer Doudna on the Brave New World Being Ushered In by Gene Editing The technology’s promise can sound like science fiction—it might help us adapt to a radically different climate ...
Jennifer Doudna on the Brave New World Being Ushered In by Gene Editing The technology’s promise can sound like science fiction—it might help us adapt to a radically different climate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback